Converging multi-modal evidences for the primary prevention of Alzheimer's dementia...International Society for Gerontechnology 13th World Conference, October 22-26, 2022, Daegu, South Korea.
Purpose Predicting risk of Alzheimer's disease for the primary prevention and early intervention. Method We investigated the performance of combining multi-modal biomarkers obtained from GWAS study (n=14,000). We first predict the lifetime risk of AD using the ethnicity adjusted SNVs incorporating t...
| Publicado en: | Gerontechnology Vol. 21; pp. 4 - 5 |
|---|---|
| Autores principales: | , , |
| Formato: | abstract proceedings research Journal Article |
| Publicado: |
International Society for Gerontechnology
Oct2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=161396105&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 161396105 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15691101 904R jtl: Gerontechnology issn: 15691101 maglogo: N pubinfo: dt: Oct2022 vid: 21 pid: 54298 pub: International Society for Gerontechnology artinfo: ui: 161396105 161396105 161396105 10.4017/gt.2022.21.s.821.4.sp3 161396105 ppf: 4 ppct: 1 formats: tig: atl: Converging multi-modal evidences for the primary prevention of Alzheimer's dementia...International Society for Gerontechnology 13th World Conference, October 22-26, 2022, Daegu, South Korea. aug: au: Gim, J. S. Kim, Y. T. Lee, K. H. affil: Department of Biomedical Science, Chosun University, Gwangju, Republic of Korea sug: subj: Alzheimer's Disease Prevention and Control Alzheimer's Disease Risk Factors Risk Assessment Early Intervention Prediction Models Congresses and Conferences South Africa South Africa ab: Purpose Predicting risk of Alzheimer's disease for the primary prevention and early intervention. Method We investigated the performance of combining multi-modal biomarkers obtained from GWAS study (n=14,000). We first predict the lifetime risk of AD using the ethnicity adjusted SNVs incorporating the prior genome-wide association (GWA) knowledge and predict the onset year for those with high lifetime risk by learning neuropsychological test scores and life-log (sleep quality and daily activity) information. Results and discussion When validated with three independent samples, the lifetime risk of AD using the proposed genomic prediction showed 75.3% of average accuracy (max 79.1%) with 74.8% and 73.7% of average sensitivity (max 80.5%) and specificity (73.7%), respectively. For those with high risk, we predicted onset within two years, our deep learning model showed 77.4% of accuracy. Strict blind test and application of the proposed model on GARD cohort shows its validity in application for screening and prevention of AD patients, especially in preclinical stage. pubtype: Academic Journal doctype: abstract proceedings research Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|